BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18350569)

  • 1. SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion.
    Yunker CK; Golembieski W; Lemke N; Schultz CR; Cazacu S; Brodie C; Rempel SA
    Int J Cancer; 2008 Jun; 122(12):2735-43. PubMed ID: 18350569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: high SPARC secretion correlates with decreased migration on vitronectin.
    Menon PM; Gutierrez JA; Rempel SA
    Int J Oncol; 2000 Oct; 17(4):683-93. PubMed ID: 10995878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins.
    Rempel SA; Golembieski WA; Fisher JL; Maile M; Nakeff A
    J Neurooncol; 2001 Jun; 53(2):149-60. PubMed ID: 11716067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo.
    Schultz C; Lemke N; Ge S; Golembieski WA; Rempel SA
    Cancer Res; 2002 Nov; 62(21):6270-7. PubMed ID: 12414657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSP27 mediates SPARC-induced changes in glioma morphology, migration, and invasion.
    Golembieski WA; Thomas SL; Schultz CR; Yunker CK; McClung HM; Lemke N; Cazacu S; Barker T; Sage EH; Brodie C; Rempel SA
    Glia; 2008 Aug; 56(10):1061-75. PubMed ID: 18442089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas.
    Jensen RL; Ragel BT; Whang K; Gillespie D
    J Neurooncol; 2006 Jul; 78(3):233-47. PubMed ID: 16612574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells.
    Kupprion C; Motamed K; Sage EH
    J Biol Chem; 1998 Nov; 273(45):29635-40. PubMed ID: 9792673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas.
    Seno T; Harada H; Kohno S; Teraoka M; Inoue A; Ohnishi T
    Int J Oncol; 2009 Mar; 34(3):707-15. PubMed ID: 19212676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC.
    Vajkoczy P; Menger MD; Goldbrunner R; Ge S; Fong TA; Vollmar B; Schilling L; Ullrich A; Hirth KP; Tonn JC; Schmiedek P; Rempel SA
    Int J Cancer; 2000 Jul; 87(2):261-8. PubMed ID: 10861485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor microRNA‑613 inhibits glioma cell proliferation, invasion and angiogenesis by targeting vascular endothelial growth factor A.
    Yu X; Wang W
    Mol Med Rep; 2017 Nov; 16(5):6729-6735. PubMed ID: 28901424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways.
    Zhao LN; Wang P; Liu YH; Cai H; Ma J; Liu LB; Xi Z; Li ZQ; Liu XB; Xue YX
    Cell Signal; 2017 Jan; 30():142-153. PubMed ID: 27693218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells.
    Zhang Y; Zhang N; Dai B; Liu M; Sawaya R; Xie K; Huang S
    Cancer Res; 2008 Nov; 68(21):8733-42. PubMed ID: 18974115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
    Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
    J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
    Wang C; Li Y; Chen H; Zhang J; Zhang J; Qin T; Duan C; Chen X; Liu Y; Zhou X; Yang J
    Cancer Lett; 2017 Aug; 402():131-141. PubMed ID: 28602979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model.
    Osterberg N; Ferrara N; Vacher J; Gaedicke S; Niedermann G; Weyerbrock A; Doostkam S; Schaefer HE; Plate KH; Machein MR
    Neuro Oncol; 2016 Jul; 18(7):939-49. PubMed ID: 26951383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cDNA array analysis of SPARC-modulated changes in glioma gene expression.
    Golembieski WA; Rempel SA
    J Neurooncol; 2002 Dec; 60(3):213-26. PubMed ID: 12510773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HSP27 alone or in combination with pAKT inhibition as therapeutic approaches to target SPARC-induced glioma cell survival.
    Schultz CR; Golembieski WA; King DA; Brown SL; Brodie C; Rempel SA
    Mol Cancer; 2012 Apr; 11():20. PubMed ID: 22480225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas.
    Rempel SA; Golembieski WA; Ge S; Lemke N; Elisevich K; Mikkelsen T; Gutiérrez JA
    J Neuropathol Exp Neurol; 1998 Dec; 57(12):1112-21. PubMed ID: 9862633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin promotes glioma angiogenesis through vascular endothelial growth factor and basic fibroblast growth factor in vitro and in vivo.
    Wang P; Zhen H; Zhang J; Zhang W; Zhang R; Cheng X; Guo G; Mao X; Wang J; Zhang X
    Mol Carcinog; 2012 Jul; 51(7):586-95. PubMed ID: 21761458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis of glioma: evaluation of ultrastructural characteristics of microvessels and tubular bodies (Weibel-Palade) in endothelial cells and immunohistochemical findings with VEGF and p53 protein.
    Miyagami M; Katayama Y
    Med Mol Morphol; 2005 Mar; 38(1):36-42. PubMed ID: 16158178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.